Related Experiment Video
Updated: Mar 4, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
864
Emerging therapies for acute myeloid leukemia
Caner Saygin1, Hetty E Carraway2,3
1Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Journal of Hematology & Oncology
|April 20, 2017
Summary
Novel agents show promise for treating acute myeloid leukemia (AML), a heterogeneous cancer. These new therapies, including epigenetic modifiers and targeted inhibitors, offer new treatment options beyond traditional chemotherapy.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Acute myeloid leukemia (AML) exhibits significant clinical and biological heterogeneity.
- Current chemotherapy-directed management for AML has seen limited advancement in recent decades.
- Despite challenges, novel therapeutic agents are emerging with demonstrated clinical activity.
Purpose of the Study:
- To review novel agents and their potential role in managing acute myeloid leukemia (AML).
- To highlight emerging drug classes and their mechanisms of action in AML treatment.
- To discuss the current landscape of investigational therapies for AML.
Main Methods:
- Review of current literature on novel therapeutic agents for AML.
- Categorization of emerging agents based on their mechanisms of action.
- Analysis of clinical activity reported for single agents and combination therapies.
Main Results:
- Various novel agents, including isocitrate dehydrogenase (IDH) inhibitors and vadastuximab, show clinical activity in AML.
- Emerging drug classes encompass novel cytotoxic chemotherapies, epigenetic modifiers, FLT3 inhibitors, and antibody-drug conjugates.
- These agents are being investigated as monotherapies or in combination with standard chemotherapy regimens.
Conclusions:
- Novel agents offer promising therapeutic strategies for acute myeloid leukemia (AML).
- The development of targeted therapies and epigenetic modifiers represents a significant advancement.
- Ongoing clinical investigations are crucial for integrating these agents into AML treatment paradigms.
Related Concept Videos
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:21Stem Cell Therapy for Tissue Regeneration
4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
01:22Bone Marrow Sampling and Transplants
1.9K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.9K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:15Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K